MedicGo
Lymphocytotoxicity and immunosuppression by organotin compounds. Suppression of graft-versus-host reactivity, blast transformation, and E-rosette formation by di-n-butyltindichloride and di-n-octyltindichloride.
Metadata
JournalImmunopharmacologyNot FoundDate
1979-Jul
Type
Journal Article
Comparative Study
Volume
1979-Jul / 1 : 343-55
Author
Seinen W , Vos JG , Brands R , Hooykaas H
DoiPMIDMESH
Animals
Cell Count
Cytotoxicity, Immunologic
Graft vs Host Reaction
Humans
Lymphocyte Activation
Lymphoid Tissue
Organotin Compounds
Rats
Rosette Formation
Species Specificity
T-Lymphocytes
Thymus Gland
Abstract
Di-n-butyltindichloride (DBTC) and di-n-octyltindichloride (DOTC) represent a new group of organometallic compounds with antilymphocytic properties. In rats they induce lymphocyte depletion in thymus and thymus-dependent areas of spleen and peripheral lymph nodes without signs of myelotoxicity or a generalized toxicity. The number and viability of cells isolated from thymus and peripheral lymphoid organs was severely decreased, whereas the number and viability of bone marrow cells was not reduced. Immunosuppressive properties of DBTC and DOTC are indicated, in this study, by a severe decrease of the graft-versus-host response and the response to the T-cell mitogens phytohemagglutinin and concanavalin A. The T-cell selectivity of these compounds is discussed. In vitro DBTC and DTOC are extremely cytotoxic. Blast transformation of human as well as rat thymocytes was already inhibited at concentrations as low as 0.02 micrograms DBTC (or 0.1 micrograms DOTC) ml medium. Also the E-rosette formation was inhibited at very low drug levels. The similarity of effects upon rat and human lymphocytes suggests that DBTC and DOTC acts in the same manner in rat and man and offers the possibility of a therapeutic use of these compounds.
Fav
Like
Download
Share
Export
Cite
I
ImmunopharmacologyImmunopharmacology
Metadata
Location
From

No Data

© 2017 - 2020 Medicgo
Powered by some medical students